Millennium Management’s Sarepta Therapeutics SRPT Stock Holding History

Millennium Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,200	Closed	-$2.58M	–	6379
2024 Q4	$2.58M	Sell	21,200 -11,500	-35%	-$1.41M	﹤0.01%	3423
2024 Q3	$4.08M	Buy	32,700 +5,300	+19%	+$733K	﹤0.01%	3023
2024 Q2	$4.33M	Buy	27,400 +7,900	+41%	+$1.01M	﹤0.01%	2857
2024 Q1	$2.52M	Sell	19,500 -5,400	-22%	-$661K	﹤0.01%	3518
2023 Q4	$2.4M	Sell	24,900 -47,300	-66%	-$4.54M	﹤0.01%	3459
2023 Q3	$8.75M	Buy	+72,200	New	+$8.16M	﹤0.01%	2172
2023 Q2	–	Sell	-22,500	Closed	-$3.1M	–	6661
2023 Q1	$3.1M	Buy	+22,500	New	+$2.92M	﹤0.01%	3022
2021 Q3	–	Sell	-11,000	Closed	-$855K	–	7229
2021 Q2	$855K	Buy	+11,000	New	+$834K	﹤0.01%	4809
2021 Q1	–	Sell	-41,000	Closed	-$6.99M	–	6488
2020 Q4	$6.99M	Sell	41,000 -14,900	-27%	-$2.21M	0.01%	2125
2020 Q3	$7.85K	Buy	+55,900	New	+$8.5M	0.01%	1460
2020 Q2	–	Sell	-4,100	Closed	-$401K	–	4578
2020 Q1	$401K	Buy	+4,100	New	+$469K	﹤0.01%	3013
2018 Q2	–	Sell	-100,000	Closed	-$7.41M	–	4148
2018 Q1	$7.41M	Buy	+100,000	New	+$6.67M	0.01%	1545
2016 Q3	–	Sell	-125,000	Closed	-$2.38M	–	3587
2016 Q2	$2.38M	Buy	+125,000	New	+$2.32M	0.01%	1688
2016 Q1	–	Sell	-250,000	Closed	-$9.64M	–	3635
2015 Q4	$9.64M	Buy	+250,000	New	+$8.11M	0.02%	942

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's SRPT Position: Q1 2026 in Review

Millennium Management increased its Sarepta Therapeutics (SRPT) stake by 22% in Q1 2026, buying an estimated $4.29M and bringing the position to 1,221,682 shares worth $26.6M. The position accounts for 0.01% of the portfolio, ranked #1312.

Millennium Management first reported a position in SRPT in Q2 2013 and has held it in 51 quarters since. The position peaked at $120M in Q3 2016. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

Millennium Management held 1,221,682 shares of Sarepta Therapeutics worth $26.6M as of Q1 2026.
Millennium Management bought 221,573 Sarepta Therapeutics shares in Q1 2026, an estimated $4.29M.
Sarepta Therapeutics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1312 holding.
Millennium Management first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 51 quarters since.
Millennium Management's Sarepta Therapeutics position peaked at $120M in Q3 2016.
339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.